a syndrome seen in clients receiving mixes of agents with psychopharmacological impacts and because of the additive anticholinergic impacts upon the peripheral nervous system of, among others, tricyclic antidepressants, the anti-Parkinsonian drugs, and weaker phenothiazines. The indicators are inclusive of dry mucous membranes, warm flushed face and skin, and dry mouth.

PERIPHERAL ANTICHOLINERGIC SYNDROME: "She has been diagnosed with peripheral anti-cholinergic syndrome."
Cite this page: N., Pam M.S., "PERIPHERAL ANTICHOLINERGIC SYNDROME," in, April 7, 2013, (accessed September 27, 2021).